Selected article for: "cc NC ND International license and death recovery"
Author: Souvik Maitra; Mansij Biswas; Sulagna Bhattacharjee
Title: Case- fatality rate in COVID- 19 patients: A meta-analysis of publicly accessible database
  • Document date: 2020_4_14
    • ID: 3i2jhvwn_13
    Snippet: Estimation of mortality rate at the time of outbreak is difficult because there are always a proportion of newly diagnosed cases where clinical outcome (death or recovery) is yet to happen. Secondly, total number of diagnosed cases depends upon the diagnostic strategy of the country and proportion of asymptomatic cases. Surprising high mortality were obtained when only closed cases were used in denominator; however, true mortality rate is expecte.....
    Document: Estimation of mortality rate at the time of outbreak is difficult because there are always a proportion of newly diagnosed cases where clinical outcome (death or recovery) is yet to happen. Secondly, total number of diagnosed cases depends upon the diagnostic strategy of the country and proportion of asymptomatic cases. Surprising high mortality were obtained when only closed cases were used in denominator; however, true mortality rate is expected to be smaller as a large number of suspected patients were not subjected to laboratory confirmation. So, actual mortality from COVID-19 is difficult to estimate at this point of time and it could higher than current estimation. Proportion . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • actual mortality and cc NC ND International license: 1, 2
    • actual mortality and high mortality: 1, 2, 3, 4, 5, 6
    • actual mortality and International license: 1, 2, 3
    • actual mortality and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • actual mortality and mortality rate estimation: 1
    • asymptomatic case and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8
    • asymptomatic case and close case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • asymptomatic case and high mortality: 1, 2, 3
    • asymptomatic case and International license: 1
    • asymptomatic case and large number: 1, 2, 3
    • asymptomatic case and mortality rate: 1, 2, 3, 4
    • cc NC ND International license and clinical outcome: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and close case: 1
    • cc NC ND International license and high mortality: 1, 2, 3, 4, 5, 6, 7, 8
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and laboratory confirmation: 1, 2, 3, 4, 5
    • cc NC ND International license and large number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cc NC ND International license and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • clinical outcome and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25